Goldman Sachs Group Inc Soma Logic, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.76 - $2.83 $99,686 - $160,291	-56,640 Reduced 5.26%	1,020,601 $2.58 Million
Q3 2023 May 14, 2024	BUY	$1.99 - $2.45 $112,713 - $138,768	56,640 Added 5.55%	1,077,241 $2.57 Million
Q3 2023 Nov 14, 2023	BUY	$1.99 - $2.45 $461,644 - $568,355	231,982 Added 27.45%	1,077,241 $2.57 Million
Q2 2023 May 14, 2024	BUY	$2.1 - $3.36 $293,199 - $469,119	139,619 Added 19.79%	845,259 $1.95 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $3.36 $293,199 - $469,119	139,619 Added 19.79%	845,259 $1.95 Million
Q1 2023 May 14, 2024	SELL	$2.13 - $3.6 $7,783 - $13,154	-3,654 Reduced 0.52%	705,640 $1.8 Million
Q1 2023 May 11, 2023	SELL	$2.13 - $3.6 $7,783 - $13,154	-3,654 Reduced 0.52%	705,640 $1.8 Million
Q4 2022 May 14, 2024	SELL	$2.05 - $3.47 $399,247 - $675,799	-194,755 Reduced 21.54%	709,294 $1.78 Million
Q4 2022 Feb 13, 2023	SELL	$2.05 - $3.47 $399,247 - $675,799	-194,755 Reduced 21.54%	709,294 $1.78 Million
Q3 2022 May 14, 2024	BUY	$0.63 - $5.47 $138,572 - $1.2 Million	219,957 Added 32.15%	904,049 $2.62 Million
Q3 2022 Nov 10, 2022	BUY	$0.63 - $5.47 $138,572 - $1.2 Million	219,957 Added 32.15%	904,049 $2.62 Million
Q2 2022 May 14, 2024	SELL	$4.27 - $8.26 $1.44 Million - $2.78 Million	-336,509 Reduced 32.97%	684,092 $3.09 Million
Q2 2022 Aug 15, 2022	SELL	$4.27 - $8.26 $6.13 Million - $11.9 Million	-1,436,680 Reduced 67.74%	684,092 $3.09 Million
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $14.5 Million - $23.8 Million	2,050,401 Added 2913.7%	2,120,772 $17 Million
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $738,191 - $1 Million	70,371 New	70,371 $819,000

Others Institutions Holding SLGC

# of Institutions

Shares Held

7.48M

Call Options Held

Put Options Held

View Full List

About SomaLogic, Inc.

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

More about SLGC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account